AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Clinical trials for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE explained in plain language.
Never miss a new study
Get alerted when new AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE trials appear
Sign up with your email to follow new studies for AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Common diabetes drug could slow devastating kidney disease
Disease control Recruiting nowThis large global trial is testing whether metformin, a widely used and affordable diabetes medication, can slow the decline of kidney function in people with autosomal dominant polycystic kidney disease (ADPKD). The study will enroll 1,174 adults with early-stage ADPKD to see if…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE3 • Sponsor: The University of Queensland • Aim: Disease control
Last updated Apr 02, 2026 01:10 UTC
-
New drug trial aims to slow kidney damage in genetic disease
Disease control Recruiting nowThis study is testing whether an investigational drug called ABBV-CLS-628 can safely slow the progression of autosomal dominant polycystic kidney disease (ADPKD), a genetic condition where fluid-filled cysts damage the kidneys. About 240 adults with ADPKD will receive either the …
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: AbbVie • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
First human test for new kidney disease drug begins
Disease control Recruiting nowThis is an early safety study for a new drug called AZD1613, designed for people with autosomal dominant polycystic kidney disease (ADPKD). The main goal is to see if the drug is safe and well-tolerated when given as an injection or through an IV, and to understand how the body p…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 02, 2026 15:24 UTC
-
Scientists search for early warning signs in inherited kidney disease
Knowledge-focused Recruiting nowThis study aims to understand the role of cellular stress in early-stage autosomal dominant polycystic kidney disease (ADPKD). Researchers will enroll 40 young adults (ages 18-30) with early ADPKD and healthy volunteers to compare them. Participants will provide blood and urine s…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Kidney disease drug trial seeks clues in urine
Knowledge-focused Recruiting nowThis study aims to understand how a drug called Empagliflozin affects the body's handling of important minerals like calcium and magnesium in people with an inherited form of kidney disease. Forty participants will take the drug or a placebo for two weeks while researchers measur…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Phase: PHASE2 • Sponsor: Cantonal Hospital Graubuenden • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC
-
Scientists hunt for early warning signs in inherited kidney disease
Knowledge-focused Recruiting nowThis study aims to find new biological markers in blood and urine that can better show how severe early-stage autosomal dominant polycystic kidney disease (ADPKD) is. Researchers will enroll 60 young patients (ages 15-40) with early, mild disease. They will compare different mark…
Matched conditions: AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:08 UTC